TargetTrack | Target Query Results

1 targets match your request

Target ID:JCSG-419091
Source Organism
Parabacteroides distasonis atcc 8503
Target Name
SP16569N
Target Category
biomedical,community nominated,biomedical,community nominated
Target Rationale
Inhibitors of sialidases present potential therapeutic value. The ultimate goal is to create and optimize a microbiota-targeted sialidase-inhibitor toolkit by molecular screening and structural biology.
Status
in PDB
Site
JCSG
Site ID
419091
Lab List
GNF,SSRL,UCSD
Clone available
PdCD00547804
Structure available
4fj6
Remark
Glycoside hydrolase family 33, candidate sialidase, bacterial neuraminidase repeat, intramolecular trans-sialidase, a carbohydrate binding domain
URL
http://www1.jcsg.org/...
Last Update
2016-04-02
Project List
PSI-2, PSI-3
Database References
NCBI RefSeq: YP_001304276.1, PSICNT: 228


Targets that contain a matching or similar sequence to your query are listed with the best alignments presented at the top. View the Alignment tab to see how closely a target sequence matches your query.

A target containing one or more sequences may have multiple alignments in this tab.

The Summary tab contains target-level information about a target in your search query.

The Sequence tab contains information about all the sequences defined within a target.

Links to additional annotation sources are provided for each protein sequence, as well as derived protein properties and domain annotations.

The Progress tab contains any trial-level data provided for the target.

Trials are ordered by experimental progress, with the most advanced trials listed first.

The protocols used in each trial are listed by experimental type. A green plus sign indicates protocol details specific to that trial can be found in the protocol summary page.

The Summary tab contains target-level information about a target in your search query.

The Sequence tab contains information about all the sequences defined within a target.

Links to additional annotation sources are provided for each protein sequence, as well as derived protein properties and domain annotations.

The Progress tab contains any trial-level data provided for the target.

Trials are ordered by experimental progress, with the most advanced trials listed first.

The protocols used in each trial are listed by experimental type. A green plus sign indicates protocol details specific to that trial can be found in the protocol summary page.